Blood transcriptomic signatures of Alzheimer's patients treated with a novel Alzheimer's disease drug, EHT 0202, allow identification of novel potential biomarkers correlated with treatment response and efficacy

✍ Scribed by Desire, Laurent; Carriere, Jennyfer; Blondiaux, Elodie; Lemarie, Jean-Christophe; Einstein, Rich; Beurdeley, Pascale; Pando, Matt

• Book ID: 123269153
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 53 KB
• Volume: 7
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2011.09.035